Abstracts tagged "axial spondyloarthritis and obesity"

Abstract Number: 2508 • 2017 ACR/ARHP Annual Meeting
Obese Axial Spondyloarthropathy Patients Have Worse Disease Outcomes
Gillian Fitzgerald¹, Phil Gallagher², Catherine Sullivan³, Killian O Rourke⁴, Claire Sheehy⁵, Frances Stafford⁶, Carmel Silke⁷, Muhammad Haroon⁸, Ronan Mullan⁹, Sandy Fraser¹⁰, Grainne Murphy¹¹, Shawn Chavrimootoo¹², Oliver FitzGerald¹³ and Finbar O' Shea¹, ¹Rheumatology, St James's Hospital, Dublin 8, Ireland, ²St. Vincent's University Hospital, Department of Rheumatology, Dublin, Ireland, ³Rheumatology, UCHG Ireland, Galway, Ireland, ⁴Rheumatology, Midlands Regional Hospital, Tullamore, Co Offaly, Ireland, ⁵Rheumatology, University Hospital Waterford, Waterford, Ireland, ⁶Rheumatology, Blackrock Clinic, Co Dublin, Ireland, ⁷Rheumatology, Sligo University Hospital, Sligo, Ireland, ⁸Rheumatology, Kerry General Hospital, Co Kerry, Ireland, ⁹Department of Rheumatology, Tallaght Hospital, TCD, Dublin 24, Ireland, ¹⁰Department of Rheumatology, University Hospitals Limerick, Ireland, Limerick, Ireland, ¹¹Rheumatology, Cork University Hospital, Cork, Ireland, ¹²Rheumatology, Our Lady's Hospital, Co Meath, Ireland, ¹³St. Vincent's University Hospital, Department of Rheumatology. UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland
Background/Purpose: Obesity is a worldwide public health concern, due to its association with morbidity and mortality. Existing literature looking at obesity in axial spondyloarthropathy (axSpA)…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].